Skip to main content

Advertisement

SpringerLink
Log in

How to Best Image Colorectal Liver Metastases

  • Diagnostic and Interventional Radiology Innovations in Colorectal Cancer (S Gourtsoyianni, Section Editor)
  • Published:
Current Colorectal Cancer Reports

Abstract

Purpose of Review

Colorectal liver metastases affect about half of the patients with colorectal cancer and have an impact on prognosis. Resection of liver metastases, even after downstaging with chemotherapy, improves patient survival. Several imaging modalities are available for initial detection and follow-up of liver metastases. Our purpose is to review the advantages and disadvantages of each modality and to determine which is the optimal way to evaluate colorectal liver metastases in each phase of the patient’s journey.

Recent Findings

The available evidence derives mostly from comparative studies and meta-analysis, with only few available randomized trials. MRI with DWI sequences and liver-specific contrast agents appears to be the most accurate modality for the detection of liver metastases.

Summary

Different imaging modalities can be used successfully for the detection and follow-up of colorectal liver metastases, depending on the stage of the disease and patient characteristics. A stepwise approach is recommended, instead of using all modalities in each patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–87.

    Article  CAS  PubMed  Google Scholar 

  2. van der Pool AEM, Damhuis RA, IJzermans JNM, de Wilt JHW, Eggermont AMM, Kranse R, et al. Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series. Color Dis. 2012;14:56–61.

    Article  Google Scholar 

  3. Taylor A, Primrose LW, Kelsh MF, Alexander D, Choti M, Poston G, et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol. 2012;283.

  4. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier A-M. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244:254–9.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kelly C, Cassidy J. Chemotherapy in metastatic colorectal cancer. Surg Oncol. 2007;16:65–70.

    Article  PubMed  Google Scholar 

  6. Tirumani SH, Kim KW, Nishino M, Howard SA, Krajewski KM, Jagannathan JP, et al. Update on the role of imaging in management of metastatic colorectal cancer. RadioGraphics. 2014;34:1908–28.

    Article  PubMed  Google Scholar 

  7. Westwood M, Joore M, Grutters J, et al. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver met. Heal Technol Assess. 2013. https://doi.org/10.3310/hta17160.

  8. Claudon M, Dietrich C, Choi B, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver – update 2012. Ultraschall der Medizin - Eur J Ultrasound. 2012;34:11–29.

    Article  Google Scholar 

  9. Vreugdenburg TD, Ma N, Duncan JK, Riitano D, Cameron AL, Maddern GJ (2016) Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-analysis. Int J colorectal dis 31:1739–1749. **useful meta-analysis comparing liver-specific MRI and CT.

  10. Sica GT, Ji H, Ros PR. CT and MR imaging of hepatic metastases. Am J Roentgenol. 2000;174:691–8.

    Article  CAS  Google Scholar 

  11. Schima W. Liver metastases of colorectal cancer: US, CT or MR? Cancer Imaging. 2005;5:S149–56.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Soyer P, Poccard M, Boudiaf M, Abitbol M, Hamzi L, Panis Y, et al. Detection of hypovascular hepatic metastases at triple-phase helical CT: sensitivity of phases and comparison with surgical and histopathologic findings. Radiology. 2004;231:413–20.

    Article  PubMed  Google Scholar 

  13. Wicherts DA, de Haas RJ, van Kessel CS, Bisschops RHC, Takahara T, van Hillegersberg R, et al. Incremental value of arterial and equilibrium phase compared to hepatic venous phase CT in the preoperative staging of colorectal liver metastases: an evaluation with different reference standards. Eur J Radiol. 2011;77:305–11.

    Article  PubMed  Google Scholar 

  14. Fowler KJ, Saad NE, Linehan D. Imaging approach to hepatocellular carcinoma, cholangiocarcinoma, and metastatic colorectal cancer. Surg Oncol Clin N Am. 2015;24:19–40.

    Article  PubMed  Google Scholar 

  15. Zamboni GA, Gourtsoyianni S, Sourlas E, Raptopoulos VD. Value of customized scan timing determined by tracking liver enhancement in oncology patients. J Comput Assist Tomogr. 2009;33:253–8.

    Article  PubMed  Google Scholar 

  16. Brodoefel H, Tognolini A, Zamboni GA, Gourtsoyianni S, Claussen CD, Raptopoulos V. Standardisation of liver MDCT by tracking liver parenchyma enhancement to trigger imaging. Eur Radiol. 2012;22:812–20.

    Article  CAS  PubMed  Google Scholar 

  17. Löwenthal D, Zeile M, Lim WY, Wybranski C, Fischbach F, Wieners G, et al. Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging. Eur Radiol. 2011;21:832–40.

    Article  PubMed  Google Scholar 

  18. Koh D-M, Collins DJ, Wallace T, Chau I, Riddell AM. Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases. Br J Radiol. 2012;85:980–9.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Merkle EM, Zech CJ, Bartolozzi C, et al (2016) Consensus report from the 7th international forum for liver magnetic resonance imaging. Eur Radiol 26:674–682. *consensus report by an international panel of experts in liver imaging.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Vilgrain V, Esvan M, Ronot M, Caumont-Prim A, Aubé C, Chatellier G. A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases. Eur Radiol. 2016;26:4595–615.

    Article  PubMed  Google Scholar 

  21. Zech CJ, Korpraphong P, Huppertz A, Denecke T, Kim M-J, Tanomkiat W, et al. Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases. Br J Surg. 2014;101:613–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Zech CJ, Justo N, Lang A, Ba-Ssalamah A, Kim M-J, Rinde H, et al. Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: results from the VALUE trial. Eur Radiol. 2016;26:4121–30.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Han K, Park SH, Kim KW, Kim HJ, Lee SS, Kim JC, et al. Use of liver magnetic resonance imaging after standard staging abdominopelvic computed tomography to evaluate newly diagnosed colorectal cancer patients. Ann Surg. 2015;261:480–6.

    Article  PubMed  Google Scholar 

  24. Il KS, Kim D-W, Cho JY, Park J, Lee KH, Son IT, et al. Is MRI of the liver needed during routine preoperative workup for colorectal cancer? Dis colon rectum. 2017;60:936–44.

    Article  Google Scholar 

  25. Ruers TJM, Wiering B, van der Sijp JRM, Roumen RM, de Jong KP, Comans EFI, et al. Improved selection of patients for hepatic surgery of colorectal liver metastases with 18F-FDG PET: a randomized study. J Nucl Med. 2009;50:1036–41.

    Article  PubMed  Google Scholar 

  26. Moulton C-A, Gu C-S, Law CH, et al. Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases. JAMA. 2014;311:1863.

    Article  CAS  PubMed  Google Scholar 

  27. Maffione AM, Lopci E, Bluemel C, Giammarile F, Herrmann K, Rubello D. Diagnostic accuracy and impact on management of 18F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review. Eur J Nucl Med Mol Imaging. 2015;42:152–63.

    Article  CAS  PubMed  Google Scholar 

  28. Gavra M, Syed R, Fraioli F, Afaq A, Bomanji J. PET/MRI in the upper abdomen. Semin Nucl Med. 2015;45:282–92.

    Article  PubMed  Google Scholar 

  29. Beiderwellen K, Geraldo L, Ruhlmann V, Heusch P, Gomez B, Nensa F, et al. Accuracy of [18F]FDG PET/MRI for the detection of liver metastases. PLoS One. 2015;10:e0137285.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Karaosmanoglu AD, Onur MR, Ozmen MN, Akata D, Karcaaltincaba M. Magnetic resonance imaging of liver metastasis. Semin Ultrasound, CT MRI. 2016;37:533–48.

    Article  Google Scholar 

  31. Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27:1386–422.

    Article  PubMed  Google Scholar 

  32. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Rectal Cancer V.2.2019. © National Comprehensive Cancer Network, Inc. 2019. All rights reserved. Accessed May 15th,2019. To view the most recent and c.

  33. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Colon Cancer V.1.2019. © National Comprehensive Cancer Network, Inc. 2019. All rights reserved. Accessed May 15th,2019. To view the most recent and co.

  34. Adam R, De Gramont A, Figueras J, et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist. 2012;17:1225–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Robinson PJA. The effects of cancer chemotherapy on liver imaging. Eur Radiol. 2009;19:1752–62.

    Article  PubMed  Google Scholar 

  36. Spolverato G, Vitale A, Ejaz A, Cosgrove D, Cowzer D, Cillo U, et al. Hepatic resection for disappearing liver metastasis: a cost-utility analysis. J Gastrointest Surg. 2015;19:1668–75.

    Article  PubMed  Google Scholar 

  37. van Kessel CS, Buckens CFM, van den Bosch MAAJ, van Leeuwen MS, van Hillegersberg R, Verkooijen HM. Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis. Ann Surg Oncol. 2012;19:2805–13.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Jhaveri K, Cleary S, Audet P, Balaa F, Bhayana D, Burak K, et al. Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent (gadoxetic acid). Am J Roentgenol. 2015;204:498–509.

    Article  Google Scholar 

  39. Beckers RCJ, Lambregts DMJ, Lahaye MJ, Rao S-X, Kleinen K, Grootscholten C, Beets GL, Beets-Tan RGH, Maas M (2018) Advanced imaging to predict response to chemotherapy in colorectal liver metastases – a systematic review. HPB 20:120–127. **review of the advanced modalities for predicting response to treatment.

    Article  PubMed  Google Scholar 

  40. Koh D-M, Scurr E, Collins D, Kanber B, Norman A, Leach MO, et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. Am J Roentgenol. 2007;188:1001–8.

    Article  Google Scholar 

  41. Liang H-Y, Huang Y-Q, Yang Z-X, Ying-Ding ZM-S, Rao S-X. Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases. Eur Radiol. 2016;26:2009–18.

    Article  PubMed  Google Scholar 

  42. Heijmen L, ter Voert EEGW, Oyen WJG, Punt CJA, van Spronsen DJ, Heerschap A, et al. Multimodality imaging to predict response to systemic treatment in patients with advanced colorectal cancer. PLoS One. 2015;10:e0120823.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  43. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.

    Article  CAS  PubMed  Google Scholar 

  44. Wolchok JD, Hoos A, O’Day S, et al. Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. Clin Cancer Res. 2009;15:7412–20.

    Article  CAS  PubMed  Google Scholar 

  45. Nishino M, Hatabu H, Hodi FS. Imaging of cancer immunotherapy: current approaches and future directions. Radiology. 2019;290:9–22.

    Article  PubMed  Google Scholar 

  46. Lubner MG, Smith AD, Sandrasegaran K, Sahani DV, Pickhardt PJ. CT texture analysis: definitions, applications, biologic correlates, and challenges. RadioGraphics. 2017;37:1483–503.

    Article  PubMed  Google Scholar 

  47. Lubner MG, Stabo N, Lubner SJ, del Rio AM, Song C, Halberg RB, et al. CT textural analysis of hepatic metastatic colorectal cancer: pre-treatment tumor heterogeneity correlates with pathology and clinical outcomes. Abdom Imaging. 2015;40:2331–7.

    Article  PubMed  Google Scholar 

  48. Beckers RCJ, Lambregts DMJ, Schnerr RS, Maas M, Rao SX, Kessels AGH, et al. Whole liver CT texture analysis to predict the development of colorectal liver metastases—a multicentre study. Eur J Radiol. 2017;92:64–71.

    Article  PubMed  Google Scholar 

  49. Lee SJ, Zea R, Kim DH, Lubner MG, Deming DA, Pickhardt PJ. CT texture features of liver parenchyma for predicting development of metastatic disease and overall survival in patients with colorectal cancer. Eur Radiol. 2018;28:1520–8.

    Article  PubMed  Google Scholar 

  50. Rao S-X, Lambregts DM, Schnerr RS, et al. CT texture analysis in colorectal liver metastases: a better way than size and volume measurements to assess response to chemotherapy? United Eur Gastroenterol J. 2016;4:257–63.

    Article  CAS  Google Scholar 

  51. Zhang H, Li W, Hu F, Sun Y, Hu T, Tong T. MR texture analysis: potential imaging biomarker for predicting the chemotherapeutic response of patients with colorectal liver metastases. Abdom Radiol. 2019;44:65–71.

    Article  Google Scholar 

  52. ESR. Magnetic resonance fingerprinting - a promising new approach to obtain standardized imaging biomarkers from MRI. Insights Imaging. 2015;6:163–5.

    Article  Google Scholar 

  53. Ma D, Gulani V, Seiberlich N, Liu K, Sunshine JL, Duerk JL, et al. Magnetic resonance fingerprinting. Nature. 2013;495:187–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Chen Y, Jiang Y, Pahwa S, Ma D, Lu L, Twieg MD, et al. MR fingerprinting for rapid quantitative abdominal imaging. Radiology. 2016;279:278–86.

    Article  PubMed  Google Scholar 

  55. Vialle R, Boucebci S, Richer J-P, Velasco S, Herpe G, Vesselle G, et al. Preoperative detection of hepatic metastases from colorectal cancer: prospective comparison of contrast-enhanced ultrasound and multidetector-row computed tomography (MDCT). Diagn Interv Imaging. 2016;97:851–5.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UOC Radiologia BR, Azienda Ospedaliera Universitaria Integrata di Verona, P.le LA Scuro 10, 37134, Verona, Italy

    G.A. Zamboni, A. Mazzaro & G. Mansueto

Authors
  1. G.A. Zamboni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Mazzaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Mansueto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G.A. Zamboni.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Diagnostic and Interventional Radiology Innovations in Colorectal Cancer

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zamboni, G., Mazzaro, A. & Mansueto, G. How to Best Image Colorectal Liver Metastases. Curr Colorectal Cancer Rep 16, 11–17 (2020). https://doi.org/10.1007/s11888-019-00447-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11888-019-00447-x

Keywords

Search

Navigation